ANI Pharmaceuticals: Q2 Earnings Insights

ANI Pharmaceuticals ANIP reported its Q2 earnings results on Monday, August 8, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

ANI Pharmaceuticals missed estimated earnings by 40.91%, reporting an EPS of $0.13 versus an estimate of $0.22.

Revenue was up $25.23 million from the same period last year.

Last quarter the company missed on EPS by $0.21 which was followed by a 2.71% drop in the share price the next day.

Here's a look at ANI Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.09	0.74	0.70	0.68
EPS Actual	-0.12	0.54	1.01	0.67
Revenue Estimate	65.03M	56.30M	49.70M	48.05M
Revenue Actual	64.48M	60.93M	52.06M	48.62M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

ANI Pharmaceuticals management provided guidance for FY 2022, expecting earnings between $1.34 and $1.62 per share.

To track all earnings releases for ANI Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.